NASH Core Curriculum: A Comprehensive Online Resource Center

Download All
Gain expert insights on foundational topics in current NASH management, including pathogenesis, risk factors, diagnostic modalities, guideline-directed management, and emerging pharmacologic treatments. Watch a series of short, focused interactive videos, download slides with key data, and join the discussion around expert-authored commentaries.
Manal F. Abdelmalek, MD, MPH
Brent A. Neuschwander-Tetri, MD
Wing-Kin Syn, MBChB, PhD, FACP, FRCP

NASH Pathogenesis

Learn about the impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease.

Brent A. Neuschwander-Tetri, MD Released: February 3, 2021

The pathogenesis of NASH is complex, but there’s insight in looking at diabetes, obesity, and insulin resistance through the lens of the liver.

Brent A. Neuschwander-Tetri, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 29, 2021 Expired: January 28, 2022

NASH Risk Factors and Prognostic Indicators

Learn about who is at risk and should be evaluated for progression to advanced fibrosis in NASH.

Manal F. Abdelmalek, MD, MPH Released: March 15, 2021

AASLD guidelines do not recommend routine screening for NAFLD or NASH, but they and other guidelines do call out patients with type 2 diabetes as warranting workup.

Manal F. Abdelmalek, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 16, 2021 Expired: March 15, 2022

Making the Diagnosis of NASH

Learn how to use noninvasive tests to identify individuals with NAFLD and determine their risk of progression to NASH fibrosis.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 27, 2021 Expired: April 26, 2022

Learn the best tools and approaches to identify NAFLD and to rule in or rule out NASH fibrosis.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Released: April 27, 2021

With the many noninvasive tests available for screening those who are at risk for NAFLD/NASH, where should we begin and what is the optimal sequence of testing? Here’s my approach.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 20, 2021 Expired: April 19, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue